These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2461891)

  • 41. Localization of radioiodinated antibody to alpha-fetoprotein in hepatoma transplanted in rats and a case report of alpha-fetoprotein antibody treatment of a hepatoma patient.
    Koji T; Ishii N; Munehisa T; Kusumoto Y; Nakamura S; Tamenishi A; Hara A; Kobayashi K; Tsukada Y; Nishi S; Hirai H
    Cancer Res; 1980 Aug; 40(8 Pt 2):3013-5. PubMed ID: 6156759
    [No Abstract]   [Full Text] [Related]  

  • 42. Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein.
    Agopian VG; Harlander-Locke MP; Markovic D; Zarrinpar A; Kaldas FM; Cheng EY; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
    JAMA Surg; 2017 Jan; 152(1):55-64. PubMed ID: 27706479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Anti-human AFP variant McAb in radioimmunodetection for primary hepatocellular carcinoma].
    Liu Y; Wu M; Zhang B
    Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):530-2. PubMed ID: 9594155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
    Sato Y; Nakata K; Kato Y; Shima M; Ishii N; Koji T; Taketa K; Endo Y; Nagataki S
    N Engl J Med; 1993 Jun; 328(25):1802-6. PubMed ID: 7684823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of the Clinical Utility of Glypican 3 as a Serum Marker for the Diagnosis of Hepatocellular Carcinoma.
    Jia X; Gao Y; Zhai D; Liu J; Cai J; Wang Y; Jing L; Du Z
    Technol Cancer Res Treat; 2016 Dec; 15(6):780-786. PubMed ID: 26370140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression and characterization of a recombinant Fab fragment derived from an anti-human alpha-fetoprotein monoclonal antibody.
    Kim SH; Song SH; Kim YJ; Park SY
    Mol Cells; 2001 Apr; 11(2):158-63. PubMed ID: 11355695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of membrane-bound alpha-fetoprotein in human hepatoma cell lines by monoclonal antibody 19F12.
    Hosokawa S; Muramatsu M; Nagaike K
    Cancer Res; 1989 Jan; 49(2):361-6. PubMed ID: 2463075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.
    Volkmann M; Müller M; Hofmann WJ; Meyer M; Hagelstein J; Räth U; Kommerell B; Zentgraf H; Galle PR
    Hepatology; 1993 Sep; 18(3):559-65. PubMed ID: 7689531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
    Yoon SK; Lim NK; Ha SA; Park YG; Choi JY; Chung KW; Sun HS; Choi MJ; Chung J; Wands JR; Kim JW
    Cancer Res; 2004 Aug; 64(15):5434-41. PubMed ID: 15289352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aberrant expression of a fetal glycoprotein 68 in hepatocellular carcinoma: a comparative study on the expression of alpha-fetoprotein and carcinoembryonic antigen.
    Kato M; Shinozawa T; Kato S; Terada T
    Histol Histopathol; 2004 Jul; 19(3):701-6. PubMed ID: 15168330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monoclonal antibodies against human alpha-fetoprotein more reactive to cell-surface alpha-fetoprotein than to free alpha-fetoprotein.
    Masuda K; Nagata S; Harada S; Hirano K; Takagishi Y
    Microbiol Immunol; 1992; 36(8):873-84. PubMed ID: 1282196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Studies on alpha fetoprotein. 2. Investigation of the factors influencing alpha fetoprotein production in primary hepatocellular carcinoma].
    Okamoto Y
    Nihon Shokakibyo Gakkai Zasshi; 1974 Nov; 71(11):1143-50. PubMed ID: 4142800
    [No Abstract]   [Full Text] [Related]  

  • 54. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma.
    Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L
    World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
    Li J; Wei L
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):246-50. PubMed ID: 24915815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrophoresis and electro-affinity transfer with specific antibodies to alpha-fetoprotein for detection of circulating immune complexes of alpha-fetoprotein.
    Taketa K; Ichikawa E; Taga H; Hirai H
    Acta Med Okayama; 1984 Aug; 38(4):409-13. PubMed ID: 6208755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT.
    Kim HO; Kim JS; Shin YM; Ryu JS; Lee YS; Lee SG
    J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.
    Huang S; Jiang F; Wang Y; Yu Y; Ren S; Wang X; Yin P; Lou J
    Tumour Biol; 2017 Jun; 39(6):1010428317705763. PubMed ID: 28621228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levels.
    Du MQ; Hutchinson WL; Johnson PJ; Williams R
    Cancer; 1991 Jan; 67(2):476-80. PubMed ID: 1702350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radioimmunodetection of residual, recurrent or metastatic germ cell tumors using technetium-99 anti-(alpha-fetoprotein) Fab' fragment.
    Amato R; Kim EE; Prow D; Andreopoulos D; Kasi LP
    J Cancer Res Clin Oncol; 2000 Mar; 126(3):161-7. PubMed ID: 10741910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.